Publications by authors named "Kreis M"

Background: Commissioning for health services has been implemented as one approach to improve the quality and access to healthcare for First Nations, regional and remote populations. This review systematically scoped the literature for studies that described or evaluated the governance, funding, implementation and outcomes from health service commissioning targeting these groups in Canada, Australia, Aotearoa/New Zealand and the United States (CANZUS nations).

Methods: Seventeen databases were searched for relevant peer reviewed and grey literature studies published in English from 2010 to 2023.

View Article and Find Full Text PDF

We present, to our knowledge, the first methodological study aimed at enhancing the prognostic power of Cox regression models, widely used in survival analysis, through optimized data selection. Our approach employs a novel two-stage mechanism: by framing the prognostic stratum matching problem intuitively, we select prognostically representative patient observations to create a more balanced training set. This enables the model to assign equal attention to distinct prognostic subgroups.

View Article and Find Full Text PDF
Article Synopsis
  • Some studies found that specific gene markers (KRAS or BRAF) combined with other health factors can lead to bad results for people with liver cancer, making surgery not very helpful.
  • The research looked at data from over 1,600 patients to see how long they lived after surgery and found many didn’t survive long, especially those with risky KRAS mutations.
  • The findings suggest that in some cases, surgery might not be the best option for these patients, similar to those who only got treatment without surgery.
View Article and Find Full Text PDF

Background: To date, only two studies have compared the outcomes of patients with liver-limited BRAF V600E-mutated colorectal liver metastases (CRLMs) managed with resection versus systemic therapy alone, and these have reported contradictory findings.

Methods: In this observational, international, multicentre study, patients with liver-limited BRAF V600E-mutated CRLMs treated with resection or systemic therapy alone were identified from institutional databases. Patterns of recurrence/progression and overall survival were compared using multivariable analyses of the entire cohort and a propensity score-matched cohort.

View Article and Find Full Text PDF
Article Synopsis
  • Neoadjuvant therapy (NT) is a standard treatment for locally advanced rectal cancer, and endoscopic vacuum therapy (EVT) is used to address anastomotic leakage after rectal surgery.
  • A study analyzed 243 patients who underwent rectal resection, finding that 19.3% experienced anastomotic leakage requiring EVT, with 61.7% of these patients receiving NT.
  • Results showed no significant differences in EVT duration, healing time, treatment failure rates, or ostomy reversal between patients who received NT and those who didn't, indicating that NT does not negatively impact EVT outcomes.
View Article and Find Full Text PDF

Background: Current guidelines recommend use of adjuvant imatinib therapy for many patients with gastrointestinal stromal tumours (GISTs); however, its optimal treatment duration is unknown and some patient groups do not benefit from the therapy. We aimed to apply state-of-the-art, interpretable artificial intelligence (ie, predictions or prescription logic that can be easily understood) methods on real-world data to establish which groups of patients with GISTs should receive adjuvant imatinib, its optimal treatment duration, and the benefits conferred by this therapy.

Methods: In this observational cohort study, we considered for inclusion all patients who underwent resection of primary, non-metastatic GISTs at the Memorial Sloan Kettering Cancer Center (MSKCC; New York, NY, USA) between Oct 1, 1982, and Dec 31, 2017, and who were classified as intermediate or high risk according to the Armed Forces Institute of Pathology Miettinen criteria and had complete follow-up data with no missing entries.

View Article and Find Full Text PDF

Background: Patients with surgically resectable BRAF-mutated colorectal liver metastases (CRLM) or limited extrahepatic disease constitute a highly selective subgroup among BRAF-mutated patients, characterized by a more indolent disease biology. This is evident in their suitability for surgical resection. However, initial studies from a decade ago presented a discouraging outlook for these patients, citing early, frequent, multifocal recurrences and a very limited median overall survival (OS) of less than two years.

View Article and Find Full Text PDF

Colorectal cancer is the second most common cause of cancer death in the United States, and up to half of patients develop colorectal liver metastases (CRLMs). Notably, somatic genetic mutations, such as mutations in , , mismatch repair (MMR) genes, , and , have been shown to play a prognostic role in patients with CRLM. This review summarizes and appraises the current literature regarding the most relevant somatic mutations in surgically treated CRLM by not only reviewing representative studies, but also providing recommendations for areas of future research.

View Article and Find Full Text PDF

The purpose of this case study is to explain the development of Queensland's strategic approach to health system reform, which promotes partnership across the health system to better deliver integrated and value-based health care across the continuum of care. The new health system vision was informed by undertaking literature searches on national and international health system approaches to reform and supported by extensive consultation across Queensland with more than 1100 stakeholders. Thematic analysis was undertaken to identify key themes that were translated into a high-level vision document that communicated Queensland's renewed focus on wellness and delivering more care in the community.

View Article and Find Full Text PDF

Introduction: The role of visceral fat in disease development, particularly in Crohn´s disease (CD), is significant. However, its preoperative prognostic value for postoperative complications and CD relapse after ileocecal resection (ICR) remains unknown. This study aims to assess the predictive potential of preoperatively measured visceral and subcutaneous fat in postoperative complications and CD recurrence using magnetic resonance imaging (MRI).

View Article and Find Full Text PDF
Article Synopsis
  • A systematic review and meta-analysis were conducted to examine the effect of RAS mutation status on prognosis linked to surgical techniques (anatomic vs. nonanatomic resection) for colorectal liver metastases (CRLM).
  • The study analyzed data from 2018 patients and found that anatomic resections led to significant improvements in liver-specific and overall disease-free survival for patients with mutRAS tumors, while showing no such benefits for patients with wtRAS tumors.
  • The findings suggest that anatomic resections might be more beneficial for patients with mutRAS tumors and encourage a more tailored approach to surgery, rather than a one-size-fits-all strategy.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on evaluating the effectiveness of Node-RADS, a structured reporting system, for assessing regional lymph nodes in gastric cancer compared to individual criteria, using histopathology as a reference.
  • The research involved 91 patients with gastric adenocarcinoma, where Node-RADS scores were assigned and various criteria, including border contours, were analyzed for their diagnostic performance.
  • Findings indicate that using Node-RADS scores (≥3 and ≥4) offers better diagnostic performance and specificity than individual criteria, highlighting the advantages of structured reporting in improving lymph node assessment in gastric cancer.
View Article and Find Full Text PDF

Purpose: The outcome of radiotherapy (RT) for prostate cancer (PCA) depends on the delivered dose. While the evidence for dose-escalated RT up to 80 gray (Gy) is well established, there have been only few studies examining dose escalation above 80 Gy. We initiated the present study to assess the safety of dose escalation up to 84 Gy.

View Article and Find Full Text PDF

Aim: Surgical treatment of perianal fistulae originating from Crohn's Disease (CD) or cryptoglandular abscess (CGA) remains a challenge. Data on long-term healing rates are scarce. We aimed to evaluate the long-term success rate of mucosal advancement flap (MAF) operations.

View Article and Find Full Text PDF
Article Synopsis
  • Interleukin-6 is crucial for the advancement and poor outcomes of pancreatic ductal adenocarcinoma (PDAC), and the study investigates the effectiveness of targeting its signaling with inhibitors like SC144 and raloxifene in combination with paclitaxel.
  • In vitro results showed that the combination of paclitaxel and raloxifene significantly inhibited cell growth and increased apoptosis in pancreatic cancer cell lines, while the SC144 combination did not show similar results.
  • In an orthotopic mouse model of PDAC, both drug combinations reduced tumor weight and volume, and raloxifene's combination with paclitaxel led to lower survivin expression, indicating a potential pathway for improving chemotherapy outcomes and reducing side effects.
View Article and Find Full Text PDF

Diverticulosis and diverticular disease are ranked among the most common gastroenterological diseases and conditions. While for many years diverticulitis was found to be mainly an event occurring in the elder population, more recent work in epidemiology demonstrates increasing frequency in younger subjects. In addition, there is a noticeable trend towards more complicated disease.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the clinical effects of BRAF mutations in colorectal liver metastases (CRLMs), focusing on their implications for patient survival and treatment outcomes.
  • It included 240 patients and found that BRAF V600E mutation correlated with significantly shorter overall survival, while microsatellite stable tumors had shorter recurrence-free survival compared to MSI-high tumors.
  • The research concluded that while surgery might be ineffective for patients with extrahepatic disease, resection of neurotic disease (those that couldn't be surgically removed at first) showed promising survival rates when there was no extrahepatic spread.
View Article and Find Full Text PDF

Diverticulosis and diverticular disease are ranked among the most common gastroenterological diseases and conditions. While for many years diverticulitis was found to be mainly an event occurring in the elder population, more recent work in epidemiology demonstrates increasing frequency in younger subjects. In addition, there is a noticeable trend towards more complicated disease.

View Article and Find Full Text PDF

Background: Although primary tumor sidedness (PTS) has a known prognostic role in sporadic colorectal cancer (CRC), its role in Inflammatory Bowel Disease related CRC (IBD-CRC) is largely unknown. Thus, we aimed to evaluate the prognostic role of PTS in patients with IBD-CRC.

Methods: All eligible patients with surgically treated, non-metastatic IBD-CRC were retrospectively identified from institutional databases at ten European and Asian academic centers.

View Article and Find Full Text PDF

Background: Inflammation of the rectal remnant may affect the postoperative outcome of ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC). We aimed to determine the extent of inflammation in the anastomotic area during IPAA and to investigate the impact of proctitis on postoperative complications and long-term outcomes.

Methods: Three hundred thirty-four UC patients with primary IPAA were included in this retrospective case-control study.

View Article and Find Full Text PDF

Importance: In patients with resectable colorectal cancer liver metastases (CRLM), the choice of surgical technique and resection margin are the only variables that are under the surgeon's direct control and may influence oncologic outcomes. There is currently no consensus on the optimal margin width.

Objective: To determine the optimal margin width in CRLM by using artificial intelligence-based techniques developed by the Massachusetts Institute of Technology and to assess whether optimal margin width should be individualized based on patient characteristics.

View Article and Find Full Text PDF